Model
Edge
Moonlake Immunotherapeutics
MLTX
Filing type
4
Filing date
Jul 19, 2026
Updated
Jul 20, 2026 ยท 4:07 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership